Tnfrsf10b (TNF receptor superfamily member 10b) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Tnfrsf10b (TNF receptor superfamily member 10b) Rattus norvegicus
Symbol: Tnfrsf10b
Name: TNF receptor superfamily member 10b
RGD ID: 1308041
Description: Predicted to enable identical protein binding activity and protease binding activity. Involved in extrinsic apoptotic signaling pathway via death domain receptors; male gonad development; and response to organic cyclic compound. Predicted to be located in several cellular components, including Golgi apparatus; cell surface; and membrane raft. Biomarker of colon cancer and osteoarthritis. Human ortholog(s) of this gene implicated in carcinoma (multiple); cervical cancer; hematologic cancer (multiple); and urinary bladder cancer. Orthologous to several human genes including TNFRSF10A (TNF receptor superfamily member 10a); PARTICIPATES IN Trail mediated signaling pathway; apoptotic cell death pathway; influenza A pathway; INTERACTS WITH bisphenol A; (-)-epigallocatechin 3-gallate (ortholog); 1-fluoro-2,4-dinitrobenzene (ortholog).
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: LOC364420; tumor necrosis factor receptor superfamily member 10B; tumor necrosis factor receptor superfamily, member 10b
RGD Orthologs
Green Monkey
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81551,249,883 - 51,278,091 (+)NCBIGRCr8
mRatBN7.21544,840,386 - 44,868,318 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1544,840,386 - 44,867,467 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1548,958,259 - 48,986,200 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01550,069,754 - 50,097,693 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01546,929,101 - 46,957,032 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01551,433,853 - 51,464,215 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01555,161,595 - 55,192,095 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41550,138,439 - 50,163,254 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11550,155,031 - 50,177,989 (+)NCBI
Celera1544,522,716 - 44,548,374 (+)NCBICelera
Cytogenetic Map15p11NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-epigallocatechin 3-gallate  (ISO)
1-fluoro-2,4-dinitrobenzene  (ISO)
17beta-estradiol  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-(ethoxymethylene)-2-phenyloxazol-5-one  (ISO)
4-tert-butylphenol  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-fluorouracil  (ISO)
8-Br-cAMP  (ISO)
9-cis-retinoic acid  (ISO)
aflatoxin B1  (ISO)
all-trans-retinoic acid  (ISO)
alvocidib  (ISO)
aristolochic acid A  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (ISO)
atazanavir sulfate  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bortezomib  (ISO)
brefeldin A  (ISO)
Brevetoxin B  (ISO)
bupropion  (ISO)
butanal  (ISO)
Butylparaben  (ISO)
caffeine  (ISO)
cannabidiol  (ISO)
cantharidin  (ISO)
capsaicin  (ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
celastrol  (ISO)
celecoxib  (ISO)
chenodeoxycholic acid  (ISO)
chlorambucil  (ISO)
chloroquine  (ISO)
chlorpyrifos  (ISO)
cisplatin  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) sulfate  (ISO)
curcumin  (ISO)
cycloheximide  (ISO)
cyclosporin A  (ISO)
cylindrospermopsin  (ISO)
daunorubicin  (ISO)
deoxycholic acid  (ISO)
diarsenic trioxide  (ISO)
diazinon  (ISO)
dimethylselenide  (ISO)
dioxygen  (ISO)
dorsomorphin  (ISO)
doxorubicin  (ISO)
DuP 697  (ISO)
elemental selenium  (ISO)
embelin  (ISO)
entinostat  (ISO)
epichlorohydrin  (ISO)
esculetin  (ISO)
ethyl methanesulfonate  (ISO)
fluvastatin  (ISO)
formaldehyde  (ISO)
genistein  (ISO)
glycochenodeoxycholic acid  (ISO)
glycocholic acid  (ISO)
glycodeoxycholic acid  (ISO)
glyphosate  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
helenalin  (ISO)
hydroxyl  (ISO)
hydroxyurea  (ISO)
Ilimaquinone  (ISO)
Isoangustone A  (ISO)
Licochalcone B  (ISO)
LY294002  (ISO)
Maduramicin  (ISO)
magnesium oxide  (ISO)
melittin  (ISO)
mercury dibromide  (ISO)
metformin  (ISO)
methotrexate  (ISO)
methyl methanesulfonate  (ISO)
methylmercury chloride  (ISO)
metiram  (ISO)
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide  (ISO)
N-acetyl-L-cysteine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-Nitrosopyrrolidine  (ISO)
nefazodone  (ISO)
nickel atom  (ISO)
Nonidet P-40  (ISO)
NS-398  (ISO)
nystatin  (ISO)
o-anisidine  (ISO)
O-methyleugenol  (ISO)
ouabain  (ISO)
ozone  (ISO)
p-menthan-3-ol  (ISO)
paclitaxel  (ISO)
paraquat  (ISO)
Pendulone  (ISO)
Pentoxifylline  (ISO)
perfluorooctanoic acid  (ISO)
phenethyl caffeate  (ISO)
phenylmercury acetate  (ISO)
propanal  (ISO)
propylparaben  (ISO)
pyrethrins  (ISO)
quercetin  (ISO)
resveratrol  (ISO)
SB 431542  (ISO)
SC-58125  (ISO)
selenium atom  (ISO)
sesquiterpene  (ISO)
sodium arsenate  (ISO)
sulforaphane  (ISO)
sulindac sulfide  (ISO)
sunitinib  (ISO)
temozolomide  (ISO)
thalidomide  (ISO)
thymoquinone  (ISO)
trichostatin A  (ISO)
triclosan  (ISO)
Triptolide  (ISO)
troglitazone  (ISO)
valproic acid  (ISO)
vemurafenib  (ISO)
vismodegib  (ISO)
vorinostat  (ISO)
zinc atom  (ISO)
zinc(0)  (ISO)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component
cell surface  (IBA,ISO)
cytosol  (ISO)
Golgi apparatus  (ISO)
membrane raft  (ISO)
plasma membrane  (IBA,ISO)

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View

References - curated
# Reference Title Reference Citation
1. Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis. Bousserouel S, etal., Int J Oncol. 2010 Jun;36(6):1485-90.
2. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma. Diegmann J, etal., Int J Mol Med. 2006 Sep;18(3):395-403.
3. Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model. Estes JM, etal., Gynecol Oncol. 2007 May;105(2):291-8. Epub 2007 Feb 15.
4. TRAIL signalling: decisions between life and death. Falschlehner C, etal., Int J Biochem Cell Biol. 2007;39(7-8):1462-75. Epub 2007 Feb 14.
5. Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Fernandez V, etal., Haematologica. 2004 Nov;89(11):1322-31.
6. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
7. Death receptor response in rodent testis after mono-(2-ethylhexyl) phthalate exposure. Giammona CJ, etal., Toxicol Appl Pharmacol. 2002 Dec 1;185(2):119-27.
8. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
9. Expression of tumor necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in rat testis during development. Grataroli R, etal., Biol Reprod 2002 Jun;66(6):1707-15.
10. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts. Grzasko N, etal., Haematologica. 2006 Mar;91(3):386-9.
11. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Lamy V, etal., Carcinogenesis. 2007 Jul;28(7):1575-81. Epub 2007 Apr 13.
12. TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Lee SW, etal., Arthritis Rheum. 2004 Feb;50(2):534-42.
13. [Expression of tumor necrosis factor related apoptosis inducing ligand and its receptor in thymus during early post-burn stage in rat with severe burns] Leng XF, etal., Zhonghua Shao Shang Za Zhi. 2007 Jun;23(3):184-7.
14. Anti-DR5 mAb ameliorate adjuvant arthritis rats through inducing synovial cells apoptosis. Li W, etal., Exp Biol Med (Maywood). 2009 Dec;234(12):1468-76.
15. Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer. McCarthy MM, etal., Clin Cancer Res. 2005 Jul 15;11(14):5188-94.
16. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
17. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
18. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer. Pennarun B, etal., Biochim Biophys Acta. 2010 Apr;1805(2):123-40. Epub 2009 Dec 2.
19. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
20. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
21. GOA pipeline RGD automated data pipeline
22. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
23. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
24. Comprehensive gene review and curation RGD comprehensive gene curation
25. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model. Straughn JM Jr, etal., Gynecol Oncol. 2006 Apr;101(1):46-54. Epub 2005 Nov 4.
26. Differential apoptosis gene expression in pediatric tumors of the kidney. Takamizawa S, etal., J Pediatr Surg. 2000 Feb;35(2):390-5.
27. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Teng MW, etal., Cancer Res. 2007 Aug 1;67(15):7495-504.
28. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women. Valladares A, etal., Cancer Genet Cytogenet. 2006 Oct 15;170(2):147-51.
29. Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. Wolf S, etal., Int J Cancer. 2006 Apr 1;118(7):1831-5.
30. Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model. Zhang L, etal., Cancer Lett. 2007 Jun 18;251(1):146-57. Epub 2006 Dec 20.
Additional References at PubMed
PMID:18165900   PMID:19090789   PMID:19593445   PMID:21785459   PMID:22240897   PMID:22286051   PMID:22952982   PMID:31473246  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr81551,249,883 - 51,278,091 (+)NCBIGRCr8
mRatBN7.21544,840,386 - 44,868,318 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1544,840,386 - 44,867,467 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1548,958,259 - 48,986,200 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01550,069,754 - 50,097,693 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01546,929,101 - 46,957,032 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01551,433,853 - 51,464,215 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01555,161,595 - 55,192,095 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41550,138,439 - 50,163,254 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11550,155,031 - 50,177,989 (+)NCBI
Celera1544,522,716 - 44,548,374 (+)NCBICelera
Cytogenetic Map15p11NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38823,190,452 - 23,225,102 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl823,190,452 - 23,225,102 (-)EnsemblGRCh38hg38GRCh38
GRCh37823,047,965 - 23,082,615 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36823,104,915 - 23,138,584 (-)NCBINCBI36Build 36hg18NCBI36
Build 34823,104,915 - 23,138,584NCBI
Celera822,011,569 - 22,045,255 (-)NCBICelera
Cytogenetic Map8p21.3NCBI
HuRef821,594,946 - 21,628,637 (-)NCBIHuRef
CHM1_1823,251,086 - 23,284,807 (-)NCBICHM1_1
T2T-CHM13v2.0823,465,337 - 23,499,970 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm391470,004,921 - 70,021,860 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1470,004,921 - 70,021,860 (+)EnsemblGRCm39 Ensembl
GRCm381469,767,472 - 69,784,411 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1469,767,472 - 69,784,411 (+)EnsemblGRCm38mm10GRCm38
MGSCv371470,167,279 - 70,184,218 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361468,502,609 - 68,519,491 (+)NCBIMGSCv36mm8
Celera1467,301,078 - 67,318,034 (+)NCBICelera
Cytogenetic Map14D2NCBI
cM Map1436.1NCBI
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan1-v2741,692,326 - 41,732,181 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1817,422,892 - 17,459,408 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0822,440,502 - 22,476,790 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1819,378,547 - 19,414,724 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl819,378,547 - 19,414,724 (-)Ensemblpanpan1.1panPan2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1147,344,788 - 7,371,086 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2147,869,520 - 7,886,618 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1821,318,987 - 21,351,641 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl821,315,149 - 21,351,673 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605220,871,352 - 20,907,523 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0


Variants in Tnfrsf10b
134 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:138
Count of miRNA genes:104
Interacting mature miRNAs:125
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2298549Neuinf12Neuroinflammation QTL 123.5nervous system integrity trait (VT:0010566)spinal cord beta-2 microglobulin mRNA level (CMO:0002125)15155302115Rat
10401805Kidm51Kidney mass QTL 51kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)1530632945306329Rat
738017Hcas7Hepatocarcinoma susceptibility QTL 72.91liver integrity trait (VT:0010547)liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464)15226636846921453Rat
1582251Gluco24Glucose level QTL 243.20.0008blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)15553075650530756Rat
631273Lecl2Lens clarity QTL 20.001lens clarity trait (VT:0001304)age of onset/diagnosis of cataract (CMO:0001584)151059608955596089Rat
2300167Bmd63Bone mineral density QTL 635.90.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)151111114256111142Rat
2300173Bmd62Bone mineral density QTL 6212.80.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)151111114256111142Rat
2293688Bss29Bone structure and strength QTL 295.310.0001femur morphology trait (VT:0000559)femur midshaft cortical cross-sectional area (CMO:0001663)151111114256111142Rat
2317750Glom26Glomerulus QTL 264.3urine protein amount (VT:0005160)urine protein level (CMO:0000591)151249614165205939Rat
61424Scl1Serum cholesterol level QTL 17.70.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)151672552880672115Rat
1331729Rf42Renal function QTL 423.071kidney blood vessel physiology trait (VT:0100012)absolute change in renal blood flow rate (CMO:0001168)151736289773690657Rat
2324620Coatc3Coat color QTL 3coat/hair pigmentation trait (VT:0010463)pigmented coat/hair area to total coat/hair area ratio (CMO:0001810)151985656646187442Rat
10054130Srcrt8Stress Responsive Cort QTL 82.180.0085blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)152211793367117933Rat
1578646Bmd18Bone mineral density QTL 185.2femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)152280624098288169Rat
1578647Bmd17Bone mineral density QTL 174femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)152280624098288169Rat
1578660Bss19Bone structure and strength QTL 194.3femur morphology trait (VT:0000559)bone trabecular cross-sectional area (CMO:0002311)152280624098288169Rat
1582214Stl21Serum triglyceride level QTL 213.10.022blood triglyceride amount (VT:0002644)serum triglyceride level (CMO:0000360)152803066582262678Rat
1582227Gluco30Glucose level QTL 303.60.0003blood glucose amount (VT:0000188)absolute change in blood glucose level area under curve (CMO:0002034)152803066582262678Rat
1582228Epfw3Epididymal fat weight QTL 34.10.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)152803066582262678Rat
1582242Gluco28Glucose level QTL 283.30.0008blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)152803066582262678Rat
1582244Bw79Body weight QTL 7940.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)152803066582262678Rat
2293691Bmd37Bone mineral density QTL 376.60.0001femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)153361105871477291Rat
2293686Bmd36Bone mineral density QTL 367.40.0001femur strength trait (VT:0010010)femoral neck ultimate force (CMO:0001703)153361105871477291Rat
1598828Glom14Glomerulus QTL 142.5kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)153405413979054139Rat
7411725Strs7Sensitivity to stroke QTL 73.8cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)154028990149308583Rat
2306968Anxrr23Anxiety related response QTL 234.83reflex trait (VT:0001961)amplitude of the acoustic startle response (CMO:0001520)154063126846187442Rat
1300144Rf23Renal function QTL 233.61renal blood flow trait (VT:2000006)absolute change in renal vascular resistance (CMO:0001900)154063126898288169Rat



RefSeq Acc Id: ENSRNOT00000066128   ⟹   ENSRNOP00000063335
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1544,840,386 - 44,867,467 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000077758   ⟹   ENSRNOP00000071012
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1544,840,591 - 44,866,421 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000093234   ⟹   ENSRNOP00000076261
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1544,842,732 - 44,866,421 (+)Ensembl
RefSeq Acc Id: NM_001395720   ⟹   NP_001382649
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
GRCr81551,250,161 - 51,278,091 (+)NCBI
mRatBN7.21544,840,386 - 44,868,318 (+)NCBI
RefSeq Acc Id: XM_063274494   ⟹   XP_063130564
Rat AssemblyChrPosition (strand)Source
GRCr81551,249,883 - 51,274,227 (+)NCBI
Protein Sequences
Protein RefSeqs NP_001382649 (Get FASTA)   NCBI Sequence Viewer  
  XP_063130564 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein ACL51000 (Get FASTA)   NCBI Sequence Viewer  
  EDM02194 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSRNOP00000063335.5
RefSeq Acc Id: ENSRNOP00000063335   ⟸   ENSRNOT00000066128
RefSeq Acc Id: ENSRNOP00000071012   ⟸   ENSRNOT00000077758
RefSeq Acc Id: ENSRNOP00000076261   ⟸   ENSRNOT00000093234
RefSeq Acc Id: NP_001382649   ⟸   NM_001395720
- Peptide Label: precursor
- UniProtKB: A0A0G2JZE1 (UniProtKB/TrEMBL),   B8YBG7 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_063130564   ⟸   XM_063274494
- Peptide Label: isoform X1
Protein Domains
Death   TNFR-Cys

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-A0A0G2JZE1-F1-model_v2 AlphaFold A0A0G2JZE1 1-337 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:1308041 AgrOrtholog
BioCyc Gene G2FUF-13252 BioCyc
Ensembl Genes ENSRNOG00000038483 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000066128.5 UniProtKB/TrEMBL
  ENSRNOT00000077758.2 UniProtKB/TrEMBL
  ENSRNOT00000093234.2 UniProtKB/TrEMBL
Gene3D-CATH 1.10.533.10 UniProtKB/TrEMBL
  Tumor Necrosis Factor Receptor, subunit A, domain 2 UniProtKB/TrEMBL
InterPro DEATH-like_dom_sf UniProtKB/TrEMBL
  Death_domain UniProtKB/TrEMBL
  TNFR/NGFR_Cys_rich_reg UniProtKB/TrEMBL
  TNFR_10 UniProtKB/TrEMBL
  TNFRSF10A/B_death UniProtKB/TrEMBL
KEGG Report rno:364420 UniProtKB/TrEMBL
Pfam Death UniProtKB/TrEMBL
  TNFR_c6 UniProtKB/TrEMBL
PhenoGen Tnfrsf10b PhenoGen
RatGTEx ENSRNOG00000038483 RatGTEx
Superfamily-SCOP SSF47986 UniProtKB/TrEMBL
  TNF receptor-like UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2020-08-13 Tnfrsf10b  TNF receptor superfamily member 10b  Tnfrsf10b  tumor necrosis factor receptor superfamily, member 10b  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2008-04-30 Tnfrsf10b  tumor necrosis factor receptor superfamily, member 10b   Tnfrsf10b_predicted  tumor necrosis factor receptor superfamily, member 10b (predicted)  'predicted' is removed 2292626 APPROVED
2005-01-12 Tnfrsf10b_predicted  tumor necrosis factor receptor superfamily, member 10b (predicted)      Symbol and Name status set to approved 70820 APPROVED